◆英語タイトル:Midatech Pharma Plc (MTPH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010976
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercialize oncology and other therapeutic products. The company’s products include gelclair, oravig, soltamox, zuplenz, ferralet 90 and aquoral. It conducts research and development programs in areas of oncology, autoimmune diseases, pipeline, Q-octreotide, opsisporin, HCC, glioblastoma and diabetes vaccine. Midatech’s products are used in treatment of diabetes, rare cancers including brain (glioblastoma), ovarian, liver and pancreatic cancer and neurological and ophthalmologic conditions. The company operates through its nanoparticle manufacturing facility in Bilbao, and research facility in Cardiff. Midatech is headquartered in Abingdon, the UK.
Midatech Pharma Plc (MTPH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Midatech Pharma Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Midatech Pharma Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Midatech Pharma Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Midatech Pharma Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Midatech Pharma Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Midatech Pharma Plc, Medical Equipment, Deal Details 10
Venture Financing 10
Midatech Raises US$16 Million In Venture Financing 10
Q Chip Raises US$3 Million Venture Financing 11
Midatech Secures US$8.2 Million In Venture Financing 12
Partnerships 13
Midatech Enters Into Joint Venture With MonoSol Rx 13
Equity Offering 14
Midatech Pharma Raises USD8 Million in Private Placement of Shares 14
Midatech Pharma to Raise USD2.7 Million in Rights Offering of Shares 15
Midatech Pharma Raises USD19.8 Million in Private Placement of Shares 16
Dara BioSciences Raises USD12.5 Million in Public Offering of Units 17
Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 19
Dara BioSciences Raises USD6 Million in Private Placement Of Shares 20
Midatech Pharma Plc – Key Competitors 21
Midatech Pharma Plc – Key Employees 22
Midatech Pharma Plc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Sep 28, 2017: Midatech Pharma: Interim results for the six months ended 30 June 2017 25
Apr 04, 2017: Midatech Pharma Announces Audited financial results for the year ended 31 December 2016 29
Jan 20, 2017: Midatech Pharma Provides Trading Update 30
Sep 02, 2016: Midatech Pharma: Interim results for the six months ended 30 June 2016 31
Apr 13, 2016: Midatech Pharma Announces Audited financial results for the year ended 31 December 2015 32
Apr 13, 2016: Midatech Pharma Audited financial results for the year ended 31 December 2015 33
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
Midatech Pharma Plc, Medical Equipment, Key Facts, 2016 2
Midatech Pharma Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Midatech Pharma Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Midatech Pharma Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Midatech Pharma Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Midatech Pharma Plc, Deals By Market, 2011 to YTD 2017 8
Midatech Pharma Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Midatech Raises US$16 Million In Venture Financing 10
Q Chip Raises US$3 Million Venture Financing 11
Midatech Secures US$8.2 Million In Venture Financing 12
Midatech Enters Into Joint Venture With MonoSol Rx 13
Midatech Pharma Raises USD8 Million in Private Placement of Shares 14
Midatech Pharma to Raise USD2.7 Million in Rights Offering of Shares 15
Midatech Pharma Raises USD19.8 Million in Private Placement of Shares 16
Dara BioSciences Raises USD12.5 Million in Public Offering of Units 17
Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 19
Dara BioSciences Raises USD6 Million in Private Placement Of Shares 20
Midatech Pharma Plc, Key Competitors 21
Midatech Pharma Plc, Key Employees 22
Midatech Pharma Plc, Subsidiaries 23
Midatech Pharma Plc, Joint Venture 24